ANPDFMar 271 minResearchIntraBio Media Release | March 26, 2024IntraBio Announces U.S. FDA Accepts New Drug Application for IB1001 for the Treatment of Niemann-Pick disease type C Read the full...
ANPDFMar 141 minResearchAzafaros Media Release | March 12, 2024Azafaros announces completion of 12-week Phase 2 RAINBOW study evaluating lead asset nizubaglustat in rare disease patients.
ANPDFMar 51 minResearchZevra Therapeutics Media Release | March 4, 2024Zevra Therapeutics Provides FDA Update On The PDUFA Action Date For Arimoclomol As A Treatment For Niemann-Pick Disease Type C Read the...
ANPDFFeb 81 minResearchIntraBio Media Release | February 7, 2024The New England Journal of Medicine has published a "Science behind the study" editorial on IB1001 Read the full announcement from...